mybacs® ist ein Schweizer Unternehmen spezialisiert auf das menschliche Mikrobiom.
Location: Switzerland, Zug
Employees: 11-50
Founded date: 2019
Investors 3
| Date | Name | Website |
| - | Joyance Pa... | joyancepar... |
| 03.09.2021 | WENVEST Ca... | wenvest.ca... |
| - | naturalX H... | naturalx.v... |
Mentions in press and media 12
| Date | Title | Description |
| 03.09.2025 | +++ Tiger Global +++ 0TO9 +++ Bind-X +++ Bayes Esports +++ Heatle +++ RobCo +++ mybacs +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Mittwoch, 3. September). #STARTUPLAND SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt. ... |
| 13.08.2025 | Sports, energy and health startups set for growth | The SEF.Growth High Potential Label by the Swiss Economic Forum recognises companies demonstrating robust growth strategies and high potential for significant market impact. The label serves as a seal of quality, enhancing startups' credib... |
| 17.02.2025 | The Rise of naturalX Health Ventures: A New Era in Consumer Health Investment | In the bustling world of venture capital, a new player has emerged, ready to shake up the European healthcare landscape. naturalX Health Ventures has officially launched with a hefty €100 million fund, aiming to redefine consumer health. Th... |
| 17.02.2025 | €100 million for VC naturalX Health Ventures to fuel consumer health in Europe | Today, Berlin-based VC naturalX Health Ventures announced a €100 million fund to accelerate Healthcare in Europe, reportedly becoming the first specialised fund focused exclusively on the intersection of consumer and health in the European ... |
| 26.10.2023 | The Landbanking Group erhält 11 Millionen – Accel investiert in viso.ai – mybacs bekommt 5,6 Millionen | Im #DealMonitor für den 26. Oktober werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-... |
| 02.10.2022 | The Motivation Behind our Microbiome Focus | Photo by CDC on Unsplash Scientific exploration of the microbiome represents the opening of one of the greatest areas of science in decades, perhaps centuries. The biome utterly defines novel new approaches to the prevention and treatment ... |
| 02.10.2022 | The Foundation of our Food and Drink Focus | The first time we officially declared Food as a focus area was in the spring of 2018. “We see an impending tech-driven revolution in food, top to bottom,” we proclaimed. The never-ending hunt for new ingredients can indicate what people are... |
| 01.10.2020 | Trusting Your Gut: How Our Portfolio Companies are Taking Advantage of the Microbial Revolution | Last month marked an important step for microbiome science: Cambridge, MA-based biotechnology company Seres Therapeutics reported positive results from their Phase III human clinical trial of an oral microbiome therapeutic for the treatment... |
| 15.07.2020 | Mybacs wins an international investor | Founded by Sebastian Wahl and Carl-Philipp von Polheim, Mybacs aims to revolutionize the healthcare sector around the human microbiome. With their formulation of specially selected bacteria cultures (probiotics), prebiotics as well as miner... |
| 15.07.2020 | Mybacs wins an international investor |
Show more